3,4-Dihydro-6-methoxy-2,2-dimethyl-2H-1-benzopyran-4-ol

Metabolite details

Identifier

OGDIMNNYYGBSQY-UHFFFAOYSA-N

InChI Key

OGDIMNNYYGBSQY-UHFFFAOYSA-N

IUPAC name

6-methoxy-2,2-dimethyl-3,4-dihydrochromen-4-ol

Preferred name

3,4-Dihydro-6-methoxy-2,2-dimethyl-2H-1-benzopyran-4-ol

INN name

—

Synonym

—

ChEBI

CHEBI:173602

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• Disturbed Microbiota-Metabolites-Immune Interaction Network is Associated with Olfactory Dysfunction in Patients with Chronic Rhinosinusitis

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d
• Normal_vs_Abnormal